Abolfazl Zarjou is a Primary Care physician. OpenAlex indexes 73 publications with 3,003 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingNIH funding
2 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD
University of Alabama at Birmingham
FY2026$396,661R01DK134402 - Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD
University of Alabama at Birmingham
FY2025$356,995R01DK134402 - Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD
University of Alabama at Birmingham
FY2024$405,885R01DK134402
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fei Wang, MD
Cornell University
Michael Hassman, DO
Barbara Rizzardi, MD
Kimball Johnson, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”